Company Filing History:
Years Active: 2007
Title: Michael Lörges: Innovator in Medicinal Chemistry
Introduction
Michael Lörges is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Lörges holds a patent for "4-Heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein." This innovative patent describes a method for preparing hetero-tetrahydroquinolines, which can be synthesized by condensing substituted hetero-tetrahydroquinoline aldehydes or by reducing keto-substituted hetero-tetrahydroquinolines. The resulting compounds are particularly useful in the treatment of artheriosclerosis and dyslipidaemias.
Career Highlights
Michael Lörges is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work focuses on developing active compounds that can be utilized in various medicaments, showcasing his commitment to advancing healthcare solutions.
Collaborations
Throughout his career, Lörges has collaborated with esteemed colleagues such as Jürgen Stoltefuss and Gunter Schmidt. These partnerships have contributed to the successful development of innovative medicinal compounds.
Conclusion
Michael Lörges is a prominent figure in the field of medicinal chemistry, with a patent that highlights his innovative approach to treating significant health issues. His contributions continue to impact the pharmaceutical industry positively.